Enzo Biochem
ENZB
C$0.93
Share price
-0.25%
Change (1 day)
-33.87%
Change (1 year)
Categories
Operating Margin for Enzo Biochem (ENZB)
Operating Margin as of July 2025 (TTM): -28.53%
According to Enzo Biochem's latest financial reports and stock price the company's current Operating Margin is -28.53%. At the end of 2024 the company had an Operating Margin of -30.77%.
Operating Margin history for Enzo Biochem from 2001 to 2025
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2024 | -30.77% | -61.81% |
| 2023 | -80.56% | 29.29% |
| 2022 | -62.31% | -1031.49% |
| 2021 | 6.69% | -117.83% |
| 2020 | -37.52% | -1323.45% |
| 2019 | 3.07% | -127.13% |
| 2018 | -11.30% | 374.38% |
| 2017 | -2.38% | -105.28% |
| 2016 | 45.11% | -2020.86% |
| 2015 | -2.35% | -77.25% |
| 2014 | -10.32% | -48.95% |
| 2013 | -20.22% | -49.06% |
| 2012 | -39.70% | 215.86% |
| 2011 | -12.57% | -45.19% |
| 2010 | -22.93% | -12.51% |
| 2009 | -26.21% | 87.2% |
| 2008 | -14.00% | -43.78% |
| 2007 | -24.90% | -41.69% |
| 2006 | -42.71% | -455.31% |
| 2005 | 12.02% | -145.18% |
| 2004 | -26.61% | -345.22% |
| 2003 | 10.85% | -43.32% |
| 2002 | 19.14% | -8.59% |
| 2001 | 20.94% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 RadNet RDNT | 2.45% | -108.59% | 🇺🇸 USA |
 Quest Diagnostics
DGX | 11.66% | -140.87% | 🇺🇸 USA |
 LabCorp LH | 7.37% | -125.83% | 🇺🇸 USA |
 Psychemedics PMD | -9.73% | -65.90% | 🇺🇸 USA |
 Qiagen QGEN | 6.12% | -121.45% | 🇳🇱 Netherlands |
 NeoGenomics
NEO | -12.21% | -57.20% | 🇺🇸 USA |
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.